Phase II Clinical Study of the Combination Chemotherapy Regimen of Irinotecan Plus Oral Etoposide for the Treatment of Recurrent Ovarian Cancer (Tohoku Gynecologic Cancer Unit 101 Group Study)Tadahiro Shoji, Toru Sugiyama, Hideo Omi et al.|International Journal of Gynecological Cancer|2010Cited by 18